PharmaCyte Biotech, Inc. - Common Stock (PMCB)
1.3000
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 3rd, 9:50 AM EDT

PharmaCyte Biotech just reported results for the third quarter of 2024.
Via InvestorPlace · March 19, 2024

PharmaCyte Biotech just reported results for the second quarter of 2024.
Via InvestorPlace · December 18, 2023

Via Benzinga · May 11, 2023

Gainers TC BioPharm (Holdings) (NASDAQ:TCBP) stock moved upwards by 16.8% to $1.32 during Friday's after-market session. The company's market cap stands at $37.0 million.
Via Benzinga · April 22, 2022

Gainers
Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...
Via Benzinga · April 19, 2022

On Tuesday, 386 stocks made new 52-week lows.
Via Benzinga · September 26, 2023

PharmaCyte Biotech Inc (NASDAQ: PMCB) updated its activities to lift the FDA's clinical hold on PharmaCyte's treatment for locally advanced, inoperable...
Via Benzinga · February 14, 2022

Gainers
Epizyme (NASDAQ:EPZM) shares incr...
Via Benzinga · February 1, 2022

Upgrades
For Nektar Therapeutics (NASDAQ:
Via Benzinga · November 8, 2021

Gainers
Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc...
Via Benzinga · October 28, 2021

Gainers
Bio-Path Holdings (NASDAQ:BPTH) shares moved upwards by 9.69% to $5.43 during Wednesday's pre-market session. The company's market cap stands at $37.7...
Via Benzinga · October 27, 2021

Gainers
Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN) shares surged 308.1% to settle at $9.59 on Tuesday after the company signed an agreement with Waas Group for the...
Via Benzinga · October 27, 2021

PharmaCyte Biotech Inc (NASDAQ: PMCB) stock is moving higher in reaction to the first test results of the biocompatibility studies of its CypCaps trial product candidate.
These...
Via Benzinga · September 16, 2021

Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares climbed 64.4% to $14.29 after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in geographic...
Via Benzinga · September 10, 2021

Gainers
IVERIC bio, Inc. (NASDAQ: ISEE) shares surged 62.5% to close at $14.12 on Friday after Apellis Pharmaceuticals reported results from its Phase 3 DERBY and OAKS studies in...
Via Benzinga · September 13, 2021

The stock price of PharmaCyte Biotech Inc (NASDAQ: PMCB) is trading higher during premarket today.
Investors are expecting a major announcement from the company...
Via Benzinga · September 9, 2021

Gainers
Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The company's market cap stands at $51.7 million.
Cardiff...
Via Benzinga · September 9, 2021

Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via Benzinga · August 24, 2021

Gainers
Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value...
Via Benzinga · August 23, 2021

Gainers
Greenpro Capital Corp. (NASDAQ: GRNQ) rose 48.7% to $1.13 in pre-market trading. Greenpro Capital shares gained 16% on Friday after the company announced its Angkasa-X...
Via Benzinga · August 23, 2021

Gainers
GeoVax Labs, Inc.. (NASDAQ: GOVX) shares rose 72.1% to $7.40 in pre-market trading after the company announced it presented COVID-19 vaccine data at the European Society...
Via Benzinga · August 20, 2021

Toward the end of trading Thursday, the Dow traded down 0.49% to 34,790.15 while the NASDAQ fell 0.07% to 14,515.39. The S&P also fell, dropping 0.14% to 4,394.20.
The U....
Via Benzinga · August 19, 2021

Gainers
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) shares climbed 63.7% to close at $1.22 on Thursday after dropping 12% on Wednesday. Sonnet BioTherapeutics recently...
Via Benzinga · August 20, 2021

Gainers
Sonnet BioTherapeutics (NASDAQ:SONN) shares moved upwards by 110.49% to $1.57 during Thursday's regular session. Trading volume for Sonnet BioTherapeutics'...
Via Benzinga · August 19, 2021

Midway through trading Thursday, the Dow traded down 0.40% to 34,819.43 while the NASDAQ rose 0.07% to 14,535.52. The S&P also fell, dropping 0.03% to 4,398.74.
The U.S. has...
Via Benzinga · August 19, 2021